Home > Cashflow Statement > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
Cash Flow from Financing Activities

    Back to Cashflow Statement
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
Best 1M Momentum Large Cap Stocks
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results

TORRENT PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Financing Activities ₹10,151 Cr₹-2,298 Cr₹-2,780 Cr₹77 Cr₹-1,781 Cr

What is the latest Cash Flow from Financing Activities ratio of TORRENT PHARMACEUTICALS ?

The latest Cash Flow from Financing Activities ratio of TORRENT PHARMACEUTICALS is ₹10,151 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Financing Activities
Mar2026₹10,151 Cr
Mar2025₹-2,298 Cr
Mar2024₹-2,780 Cr
Mar2023₹77 Cr
Mar2022₹-1,781 Cr

How is Cash Flow from Financing Activities of TORRENT PHARMACEUTICALS Trending?

Years Cash Flow from Financing Activities % Change
Mar2026 ₹10,151 Cr
Positive
Mar2025 ₹-2,298 Cr
Negative
Mar2024 ₹-2,780 Cr
Negative
Mar2023 ₹77 Cr
Positive
Mar2022 ₹-1,781 Cr -

Compare Cash Flow from Financing Activities of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹185,279.5 Cr -1.8% 4.9% 37.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹480,047.0 Cr 3.1% 7.2% 18.3% Stock Analytics
DIVIS LABORATORIES ₹208,141.0 Cr 8.2% 19.8% 17.2% Stock Analytics
CIPLA ₹118,430.0 Cr 3.9% 0.6% 0% Stock Analytics
MANKIND PHARMA ₹106,427.0 Cr 2.9% 3.5% -0.3% Stock Analytics
DR REDDYS LABORATORIES ₹95,516.1 Cr -0.7% -14.6% -8.4% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

-1.8%

4.9%

37.2%

SENSEX

2%

1.9%

-5.2%


You may also like the below Video Courses